St Jude plans US trial for small pacing lead:
This article was originally published in Clinica
St Jude Medical is seeking FDA go-ahead to begin a trial of its small IsoFlex pacing lead, which is intended to provide doctors with a smaller passive-fixation lead for use with the firm's range of bradycardia pacemakers. The IsoFlex can be threaded through a 7F sheath, which facilitates easy insertion and manoevrability, says the St Paul, Minnesota firm, which has already submitted an application to market the product in Europe.
You may also be interested in...
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The US Food and Drug Administration posted two device-related closeout letters in November.
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.